FDA Announces Proposed Collection of Information for Human Drug Compounding Outsourcing Facilities

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, related to the registration of human drug compounding outsourcing facilities under Section 503B of the Federal Food, Drug, and Cosmetic Act.